## GNRC: Generac Holdlings Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -10.4% below STRENGTH zone (4.0-10.0%); PEG 1.37 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-14.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($121.89)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. The three-year decline in earnings might be taking its toll on Generac Holdings (NYSE:GNRC) shareholders as stock falls 3.4% over the past week**
- Source: Yahoo Finance | 20251216T103406 | Bearish | Relevance: 100%
- Generac Holdings Inc. (NYSE:GNRC) shareholders are experiencing a decline in stock value, falling 14% in the last quarter and 3.4% this past week, despite a 73% gain over three years. This underperformance is attributed to a 7.7% annualized drop in earnings per share and a 0.5% revenue decrease over the last three years. Analysts' future profit estimates suggest a need for investors to look beyond historical data for a comprehensive understanding of the company's prospects.

**2. Renewable Energy Stocks Q3 Results: Benchmarking First Solar (NASDAQ:FSLR)**
- Source: Finviz | 20251216T223200 | Somewhat-Bearish | Relevance: 76%
- The article reviews Q3 earnings for renewable energy companies, highlighting First Solar (FSLR) whose revenues met expectations but full-year guidance disappointed. It also discusses strong performances by Bloom Energy (BE) and EVgo (EVGO), while noting Generac (GNRC) and American Superconductor (AMSC) had weaker quarters. The broader market update touches on the economic climate and recent rate cuts.

**3. Is IDEX Corp Stock Underperforming the Dow?**
- Source: Markets Financial Content | 20251216T122500 | Neutral | Relevance: 66%
- IDEX Corporation (IEX) has recently outperformed the Dow Jones Industrial Average, rising 8.8% compared to the Dow's 5.5% return. However, its longer-term performance shows a significant lag, with a 20% decline over the past 52 weeks and a 14.8% drop in 2025, contrasting with the broader market's gains. Despite this underperformance, analysts maintain a "Moderate Buy" rating for IEX, with an average price target suggesting a potential 7.8% upside.

**4. Is IDEX Corp Stock Underperforming the Dow?**
- Source: Barchart.com | 20251216T172832 | Neutral | Relevance: 62%
- IDEX Corporation (IEX) has recently outperformed the Dow Jones Industrial Average with an 8.8% return compared to the Dow's 5.5% over the same period, despite a 21.1% pullback from its January peak. However, its longer-term performance shows a significant lag, with IEX down 20% over the past 52 weeks and 14.8% in 2025, while the Dow gained 10.4% and 13.5% respectively. Despite this, Wall Street analysts maintain a "Moderate Buy" rating for IEX with a price target suggesting a nearly 7.8% upside from current levels.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | JP Morgan | $200 | $200 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | JP Morgan | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.10M) |
| Sells | 3 ($2.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (-2.2%)
- Blackrock Inc.: 6.1% (-3.6%)
- State Street Corpora: 3.7% (-0.8%)
- Victory Capital Mana: 3.6% (+17.9%)
- Boston Partners: 3.3% (+7.1%)

### Key Risks

1. High beta (1.82) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_20 falling (-14.8% 5d) with bearish MACD, trend may be turning.
3. Elevated short interest (8.1%): bears positioning against stock.
4. Long-term trend broken: trading 9.7% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.37 suggests fair value with growth premium. Forward P/E 16.6x attractive for 25% earnings growth. Balance sheet: strong liquidity (2.2x). Insider selling cluster ($2.4M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.0B |
| Beta | 1.82 |
| 52W Range | $99.50 - $203.25 |
| Short Interest | 8.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.37 |
| Forward P/E | 16.6 |
| Current P/E | 20.8 |
| YoY Growth | 25.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 4.4% to -10.4% (-14.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 14.4pp (needs >4.0% for momentum thesis). AM_20 at -11.1% indicates price below own 20MA trend. Underperforming sector by 11.7pp, stock-specific weakness. Below SMA200 (0.90x), long-term trend not supportive. MACD histogram bearish (-1.24), momentum weakening. Elevated volume (1.9x 20MA), institutional activity likely. OFD pattern: -MTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -10.44% (CS: 4) | Weak |
| RSI_14 | 33.3 | Neutral |
| MACD Histogram | -1.24 | Bearish |
| vs SMA20 | 0.889x | Below |
| vs SMA50 | 0.835x | Below |
| vs SMA200 | 0.903x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $137.03
- **Stop Loss:** $121.89 (11.0% risk)
- **Target:** $152.17 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 47
- **Position Value:** $6,440.41
- **Portfolio %:** 6.44%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-11 (Est: $1.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.20 | $1.83 | -16.7% |
| 2025Q2 | $1.32 | $1.65 | +24.6% |
| 2025Q1 | $0.97 | $1.26 | +30.4% |
| 2024Q4 | $2.53 | $2.80 | +10.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*